Dr Amy Eccles

Dr Amy Eccles is a Consultant Radiologist specialising in Nuclear Medicine imaging and therapies. She completed her medical training at the University of Cambridge and underwent radiology training in London.
Bio
Dr Amy Eccles is a radionuclide radiologist specialising in oncological radionuclide therapy and imaging. Her therapy interests include:
- treatment of prostate cancers using Lutetium 177 PSMA and Radium 223 dichloride
- Lutetium 177 DOTATATE treatment of neuroendocrine tumours
- SIRT therapy for radioembolisation of liver tumours
- microparticle therapy for pancreatic tumours
- radio iodine for thyroid conditions.
Amy studied medicine at University of Cambridge gaining distinctions in both Medicine and Surgery. She undertook her radiology training in London completing her radionuclide subspecialty training at Imperial College. She qualified as a Consultant in 2014 and now works at Imperial College Healthcare NHS Trust supporting the delivery of imaging and Nuclear Medicine therapies. She continues to play an active role in research and developing radionuclide therapy services to expand treatment options for patients.
More information
22 Devonshire Place
London
W1G 6JA
- Qualified 2004
- University of Cambridge 1999-2004
- Fellow of Royal College of Radiologists 2011
- PGDip Medical Education King's College London 2016
Dr Eccles is a member of the Royal College of Radiologists and is their current Radionuclide Radiology Advisor.
She is the incoming Chair of the Intercollegiate Standing Committee for Nuclear Medicine and was a founding member of the Women's Empowerment Initiative in the European Association of Nuclear Medicine.
Amy is on the Council of The British Nuclear Medicine Society and leads a Working party within the Molecular Radiotherapy Consortium.
She is actively involved in education across radiology and nuclear medicine physician training. She is an international lecturer on nuclear medicine therapy and imaging. Amy works closely with Oncology colleagues in research and clinical practice using molecular radiotherapy.
- Consultant Radiologist Imperial College Healthcare NHS Trust
- Module Lead - Nuclear Medicine MSc, Brighton and Sussex Medical School